ORB-PR1

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameORB-PR1
Drug Alias NameORB-PR1 lymphoid programs(Orionis Biosciences Inc)ORB-PR1ORBPR1
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionCluster of differentiation 8 modulators
TargetsCluster of differentiation 8
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrionis Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrionis Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A